Literature DB >> 15947049

Extension of radiofrequency ablation of the liver by transcatheter arterial embolization with iodized oil and gelatin sponge: results in a pig model.

Kazuya Sugimori1, Akinori Nozawa, Manabu Morimoto, Kazuhito Shirato, Atsushi Kokawa, Toshifumi Saito, Kazushi Numata, Katsuaki Tanaka.   

Abstract

PURPOSE: To determine whether transcatheter arterial embolization (TAE) with iodized oil and gelatin sponge particles can be used to expand radiofrequency (RF)-induced coagulation necrosis, the morphology and histologic characteristics of ablation lesions were evaluated in the normal pig liver after three different TAE procedures.
MATERIALS AND METHODS: Ten consecutive animals with 33 ablation lesions produced with an RF ablation system were randomly assigned to one of three treatment groups and a control group: a group treated with TAE with iodized oil, a group treated with TAE with gelatin sponge, a group treated with TAE with iodized oil and gelatin sponge, and a control group in which TAE was not performed. After the completion of ablation, the lesions were excised for gross and histologic examination.
RESULTS: The longest and shortest diameters of ablation lesions were greatest in the group treated with TAE with iodized oil and gelatin sponge, followed by the groups treated with TAE with gelatin sponge and TAE with iodized oil (P < .05 vs controls, respectively). The hemorrhagic rim was also widest in the group treated with TAE with iodized oil and gelatin sponge (P < .05 vs controls), and it spread toward the liver periphery like a segmental hemorrhagic area adjacent to the ablation lesion. Histochemical staining for lactate dehydrogenase, maleate dehydrogenase, and nicotinamide adenine dinucleotide diaphorase showed what appeared to be 100% cellular destruction in all the ablation lesions and their hemorrhagic rims.
CONCLUSION: RF ablation combined with TAE with iodized oil and gelatin sponge induces the greatest area of coagulation necrosis accompanied by peripherally spreading segmental necrosis in normal pig liver tissue.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15947049     DOI: 10.1097/01.RVI.0000157780.44868.78

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  17 in total

1.  Effect of interval between transcatheter hepatic arterial embolization and radiofrequency ablation on ablated lesion size in a swine model.

Authors:  Cao Guang; Nobuyuki Kawai; Morio Sato; Isao Takasaka; Hiroki Minamiguchi; Shinya Sahara; Kouhei Nakata; Tetsuo Sonomura; Shintaro Shirai; Ichiro Mori; Renjie Yang
Journal:  Jpn J Radiol       Date:  2011-09-29       Impact factor: 2.374

2.  Ablative zone size created by radiofrequency ablation with and without chemoembolization in small hepatocellular carcinomas.

Authors:  Takashi Yamanaka; Koichiro Yamakado; Haruyuki Takaki; Atsuhiro Nakatsuka; Katsuya Shiraki; Hiroshi Hasegawa; Yoshiyuki Takei; Kan Takeda
Journal:  Jpn J Radiol       Date:  2012-05-19       Impact factor: 2.374

3.  Computed tomography fluoroscopy-guided radiofrequency ablation following intra-arterial iodized-oil injection for hepatocellular carcinomas invisible on ultrasonographic images.

Authors:  Haruyuki Takaki; Koichiro Yamakado; Atsuhiro Nakatsuka; Tomomi Yamada; Junji Uraki; Masataka Kashima; Takashi Yamanaka; Katsuya Shiraki; Yoshiyuki Takei; Kan Takeda
Journal:  Int J Clin Oncol       Date:  2011-10-22       Impact factor: 3.402

4.  Emerging local ablation techniques.

Authors:  Michael J Stone; Bradford J Wood
Journal:  Semin Intervent Radiol       Date:  2006-03       Impact factor: 1.513

5.  Microwave coagulation using a perfusion microwave electrode: Preliminary experimental study using ex vivo and in vivo liver.

Authors:  Hideto Umehara; Toshihito Seki; Ryosuke Inokuchi; Toru Tamai; Rinako Kawamura; Toshiki Asayama; Kozo Ikeda; Kazuichi Okazaki
Journal:  Exp Ther Med       Date:  2011-11-11       Impact factor: 2.447

6.  Ablation protocols and ancillary procedures in tumor ablation therapy: consensus from Japanese experts.

Authors:  Masaya Miyazaki; Toshihiro Iguchi; Haruyuki Takaki; Takashi Yamanaka; Yoshitaka Tamura; Hiroyuki Tokue; Yozo Sato; Osamu Ikeda; Tadashi Shimizu; Koichiro Yamakado
Journal:  Jpn J Radiol       Date:  2016-07-23       Impact factor: 2.374

Review 7.  Therapy of Intermediate-Stage Hepatocellular Carcinoma: Current Evidence and Clinical Practice.

Authors:  Nathan X Chai; Julius Chapiro
Journal:  Semin Intervent Radiol       Date:  2020-12-11       Impact factor: 1.513

8.  Imaging to optimize liver tumor ablation.

Authors:  Bradley B Pua; Constantinos T Sofocleous
Journal:  Imaging Med       Date:  2010-08

9.  Enhanced efficacy of radiofrequency ablation for hepatocellular carcinoma using a novel vascular disrupting agent, CKD-516.

Authors:  Su Jung Ham; YoonSeok Choi; Seul-I Lee; Jinil Kim; Young Il Kim; Jin Wook Chung; Kyung Won Kim
Journal:  Hepatol Int       Date:  2017-07-18       Impact factor: 6.047

10.  Clinical utility of radiofrequency ablation following transarterial injection of miriplatin-iodized oil suspension in small hepatocellular carcinoma.

Authors:  Ken Nakajima; Takashi Yamanaka; Atsuhiro Nakatsuka; Takaki Haruyuki; Masashi Fujimori; Yuichi Sugino; Naritaka Matsushita; Hajime Sakuma; Shuji Isaji; Yoshiyuki Takei; Koichiro Yamakado
Journal:  Jpn J Radiol       Date:  2016-07-25       Impact factor: 2.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.